WO2003028621A3 - Proteinaseinhibitoren zur therapie und diagnose von neurodegenerativen erkrankungen - Google Patents

Proteinaseinhibitoren zur therapie und diagnose von neurodegenerativen erkrankungen Download PDF

Info

Publication number
WO2003028621A3
WO2003028621A3 PCT/EP2002/010937 EP0210937W WO03028621A3 WO 2003028621 A3 WO2003028621 A3 WO 2003028621A3 EP 0210937 W EP0210937 W EP 0210937W WO 03028621 A3 WO03028621 A3 WO 03028621A3
Authority
WO
WIPO (PCT)
Prior art keywords
treating
neurodegenerative diseases
proteinase inhibitors
diagnosing neurodegenerative
diagnosing
Prior art date
Application number
PCT/EP2002/010937
Other languages
English (en)
French (fr)
Other versions
WO2003028621A2 (de
Inventor
Helmut Meyer
Joachim Klose
Claus Zabel
Original Assignee
Protagen Ag
Helmut Meyer
Joachim Klose
Claus Zabel
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Protagen Ag, Helmut Meyer, Joachim Klose, Claus Zabel filed Critical Protagen Ag
Priority to AU2002362488A priority Critical patent/AU2002362488A1/en
Publication of WO2003028621A2 publication Critical patent/WO2003028621A2/de
Publication of WO2003028621A3 publication Critical patent/WO2003028621A3/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/57—Protease inhibitors from animals; from humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8121—Serpins
    • C07K14/8125—Alpha-1-antitrypsin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Die vorliegende Erfindung betrifft ein Arzneimittel enthaltend (Serin-)Proteinaseinhibitoren, wie alpha-1-Antitrypsin, zur Prävention / Therapie und Diagnose von neurodegenerativen Erkrankungen. In einer bevorzugten Ausführungsform ist mindestens ein Proteinaseinhibitor mit mindestens einem Chaperon, vorzugsweise alpha-B-Kristallin, kombiniert.
PCT/EP2002/010937 2001-10-01 2002-09-30 Proteinaseinhibitoren zur therapie und diagnose von neurodegenerativen erkrankungen WO2003028621A2 (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2002362488A AU2002362488A1 (en) 2001-10-01 2002-09-30 Proteinase inhibitors for treating and diagnosing neurodegenerative diseases

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE2001148553 DE10148553A1 (de) 2001-10-01 2001-10-01 Proteinaseinhibitoren zur Therapie und Diagnose von neurodegenerativen Krankheiten
DE10148553.0 2001-10-01

Publications (2)

Publication Number Publication Date
WO2003028621A2 WO2003028621A2 (de) 2003-04-10
WO2003028621A3 true WO2003028621A3 (de) 2003-10-09

Family

ID=7701091

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2002/010937 WO2003028621A2 (de) 2001-10-01 2002-09-30 Proteinaseinhibitoren zur therapie und diagnose von neurodegenerativen erkrankungen

Country Status (3)

Country Link
AU (1) AU2002362488A1 (de)
DE (1) DE10148553A1 (de)
WO (1) WO2003028621A2 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006005582A1 (en) * 2004-07-12 2006-01-19 Geneprot, Inc. Polypeptide species useful for the treatment of neurological disorders
WO2008031190A1 (en) * 2006-09-15 2008-03-20 Osta Biotechnologies Inc. Alpha-1-antitrypsin as a diagnostic/prognostic indicator for neurodegenerative diseases
US20110237496A1 (en) * 2008-09-10 2011-09-29 Ilana Nathan Antinecrotic activity of alpha 1-antitrypsin
CN107998384A (zh) * 2017-12-06 2018-05-08 中山大学中山眼科中心 α1-抗胰蛋白酶应用于制备治疗神经退行性眼病的药物
EP4052723A1 (de) * 2021-03-02 2022-09-07 Grifols Worldwide Operations Limited Alpha-1-antitrypsin-dosierungsschema

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5514653A (en) * 1994-09-09 1996-05-07 Washington University Method of blocking the SEC receptor
US5959123A (en) * 1996-09-23 1999-09-28 Synphar Laboratories, Inc. 3,4-Disubstituted azetidin-2-one derivatives useful as cysteine proteinase regulators
US5981491A (en) * 1995-05-10 1999-11-09 Darwin Discovery Limited Peptidyl compounds and their therapeutic use
WO2000051624A2 (en) * 1999-03-05 2000-09-08 The Trustees Of University Technology Corporation Methods and compositions useful in inhibiting apoptosis

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5514653A (en) * 1994-09-09 1996-05-07 Washington University Method of blocking the SEC receptor
US5981491A (en) * 1995-05-10 1999-11-09 Darwin Discovery Limited Peptidyl compounds and their therapeutic use
US5959123A (en) * 1996-09-23 1999-09-28 Synphar Laboratories, Inc. 3,4-Disubstituted azetidin-2-one derivatives useful as cysteine proteinase regulators
WO2000051624A2 (en) * 1999-03-05 2000-09-08 The Trustees Of University Technology Corporation Methods and compositions useful in inhibiting apoptosis

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, vol. 281, no. 1, 16 February 2001 (2001-02-16), pages 6 - 10, ISSN: 0006-291X *
BRAIN RESEARCH BULLETIN, vol. 53, no. 2, 15 September 2000 (2000-09-15), pages 141 - 146, ISSN: 0361-9230 *
DATABASE BIOSIS [online] BIOSCIENCES INFORMATION SERVICE, PHILADELPHIA, PA, US; 15 September 2000 (2000-09-15), OHTSUKA KENZO ET AL: "Roles of molecular chaperones in the nervous system.", XP002241202, Database accession no. PREV200000541418 *
DATABASE BIOSIS [online] BIOSCIENCES INFORMATION SERVICE, PHILADELPHIA, PA, US; 16 February 2001 (2001-02-16), KAKIMURA JUN-ICHI ET AL: "BiP/GRP78-induced production of cytokines and uptake of amyloid-beta(1-42) peptide in microglia.", XP002241200, Database accession no. PREV200100180710 *
DATABASE BIOSIS [online] BIOSCIENCES INFORMATION SERVICE, PHILADELPHIA, PA, US; December 1999 (1999-12-01), WARRICK JOHN M ET AL: "Suppression of polyglutamine-mediated neurodegeneration in Drosophila by the molecular chaperone HSP70.", XP002241201, Database accession no. PREV200000062058 *
NATURE GENETICS, vol. 23, no. 4, December 1999 (1999-12-01), pages 425 - 428, ISSN: 1061-4036 *

Also Published As

Publication number Publication date
DE10148553A1 (de) 2003-04-17
AU2002362488A1 (en) 2003-04-14
WO2003028621A2 (de) 2003-04-10

Similar Documents

Publication Publication Date Title
WO2003042246A3 (en) Inhibitors of the notch signalling pathway for use in the treatment of cancer
WO2002078625A3 (en) Therapeutic combinations for cardiovascular and inflammatory indications
AP2004003035A0 (en) Inhibitors of factor xa and other serine proteasesinvolved in the coagulation cascade.
WO1995023860A3 (en) KUNITZ DOMAIN INHIBITOR PROTEINS DERIVED FROM ALZHEIMER'S AMYLOID β-PROTEIN PRECURSOR INHIBITOR
ZA964608B (en) Kunitz type plasma kallikrein inhibitors.
ZA992447B (en) Quinoxalinones as serine protease inhibitors.
WO2001066711A8 (en) Xylanase variants having altered sensitivity to xylanase inhibitors
MXPA03006224A (es) Inhibidores de cruzipaina y otras proteasas de cisteina.
ZA992445B (en) Benzoxazinones/benzothiazinones as serine protease inhibitors.
AU2001264065A1 (en) Serine protease inhibitors
WO2004082706A3 (en) Ifn-beta alone or in combination with other medicaments for treating alzheimer's disease and demens disorders
WO2002034201A3 (fr) Utilisation d'inhibiteurs de l'apoptose des pericytes pour le traitement et/ou la prevention de la retinopathie diabetique
WO2002003978A3 (en) A COMBINATION OF FBPase INHIBITORS AND ANTIDIABETIC AGENTS USEFUL FOR THE TREATMENT OF DIABETES
IL101925A0 (en) Inhibitors of cathepsin g and elastase for preventing connective tissue degradation
EP0930067A3 (de) Mmp inhibitoren zur behandlung von okularer angiogenesis
WO2001056555A3 (en) Use of cox-2 inhibitors for the treatment of constipation
WO2003011222A3 (en) Thrombin inhibitors
WO2003028621A3 (de) Proteinaseinhibitoren zur therapie und diagnose von neurodegenerativen erkrankungen
AU2002242500A1 (en) Cathepsin cysteine protease inhibitors
AU2003231865A1 (en) Alpha acyloxyacetamides for kallikrein and urokinase inhibition
WO2002057246A3 (en) Inhibitors of cruzipain and other cysteine proteases
AU2002342682A1 (en) Protease inhibitors
WO2001000189A3 (de) Kombination von mtp-inhibitoren und stoffwechselbeeinflussenden wirkstoffen und ihre verwendung in arzneimitteln
AU2001263786A1 (en) Purified proenzyme of dipeptidyl peptidase i (pro-dppi)
WO2002057248A3 (en) Inhibitors of cruzipain and other cysteine proteases

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BY BZ CA CH CN CO CR CU CZ DE DM DZ EC EE ES FI GB GD GE GH HR HU ID IL IN IS JP KE KG KP KR LC LK LR LS LT LU LV MA MD MG MN MW MX MZ NO NZ OM PH PL PT RU SD SE SG SI SK SL TJ TM TN TR TZ UA UG US UZ VC VN YU ZA ZM

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ UG ZM ZW AM AZ BY KG KZ RU TJ TM AT BE BG CH CY CZ DK EE ES FI FR GB GR IE IT LU MC PT SE SK TR BF BJ CF CG CI GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP